SKI Market

Indian Indices

Sensex

82,391.12 115.05
( 0.14%)

Global Indices

Nasdaq

49,510.88 315.37
(0.64%)

Dow Jones

6,968.07 57.00
(0.82%)

Hang Seng

58,650.11 1,329.02
(2.32%)

Nikkei 225

10,802.86 122.27
(1.14%)

Forex

USD-INR

90.93 0.06
(0.07%)

EUR-INR

107.10 -0.16
(-0.15%)

GBP-INR

122.70 -0.03
(-0.02%)

JPY-INR

0.58 0.00
(-0.63%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Gujarat Terce Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524314

INE499G01013

11.4053752

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

30.23

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	50.20	47.97	46.78	40.13	25.18	37.54
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	50.20	47.97	46.78	40.13	25.18	37.54
Other Income	0.31	0.32	0.35	0.31	0.80	0.29
Stock Adjustments	0.38	-1.04	-1.65	2.63	0.26	0.37
Total Income	50.89	47.25	45.48	43.07	26.24	38.20
EXPENDITURE :
Raw Materials	19.29	16.65	17.70	17.88	10.25	14.28
Power & Fuel Cost	0.15	0.17	0.11	0.16	0.10	0.10
Employee Cost	15.37	15.11	14.38	15.49	12.63	14.81
Other Manufacturing Expenses	0.55	0.22	0.44	1.58	0.93	1.07
Selling & Administrative Expenses	11.26	13.44	14.57	5.97	3.93	6.02
Miscellaneous Expenses	0.06	0.07	0.10	0.56	0.37	0.95
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	46.69	45.67	47.29	41.65	28.20	37.24
Operating Profit	4.20	1.59	-1.81	1.42	-1.97	0.97
Interest	0.42	0.68	0.72	0.40	0.39	0.29
Gross Profit	3.78	0.91	-2.53	1.02	-2.36	0.68
Depreciation	0.38	0.37	0.36	0.28	0.18	0.24
Profit Before Tax	3.40	0.54	-2.89	0.74	-2.54	0.44
Tax	0.16	0.00	0.00	0.00	0.00	0.21
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	4.21	0.30	-1.22	-0.13	-0.01	-0.05
Reported Net Profit	-0.98	0.24	-1.67	0.87	-2.52	0.28
Extraordinary Items	0.01	0.00	0.00	0.00	-0.18	0.00
Adjusted Net Profit	-0.99	0.24	-1.67	0.87	-2.34	0.28
Adjustment below Net Profit	0.00	0.00	0.00	0.00	-0.93	0.00
P & L Balance brought forward	-2.23	-2.48	-0.80	-1.68	1.77	1.50
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-3.21	-2.23	-2.48	-0.80	-1.68	1.77
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-1.32	0.33	-2.25	1.18	-3.40	0.37
Earnings Per Share(Adj)-Unit Curr	-1.32	0.33	-2.25	1.18	-3.40	0.37
Book Value-Unit Curr	8.26	9.58	9.25	11.50	10.33	14.97
Book Value(Adj)-Unit Curr	8.26	9.58	9.25	11.50	10.33	14.97

82,391.12 115.05 ( 0.14%)

49,510.88 315.37 (0.64%)

6,968.07 57.00 (0.82%)

58,650.11 1,329.02 (2.32%)

10,802.86 122.27 (1.14%)

90.93 0.06 (0.07%)

107.10 -0.16 (-0.15%)

122.70 -0.03 (-0.02%)

0.58 0.00 (-0.63%)